Found 4 articles for: "Tazarotene Lotion"
Meeting Patient Expectations of Topical Psoriasis Treatment: Evidence Supporting the Use of Fixed-Combination Halobetasol/Tazarotene Lotion
February 2023 | Volume 22 | Issue 2 | Original Article | 132 | Copyright © February 2023
Discordance between patient and clinician treatment goals and expectations can present a challenge to implementation of effective therapeutic plans. Because topical treatments are commonly used for pl...
Read MoreEfficacy and Safety of Tazarotene Lotion, 0.045% in the Treatment of Truncal Acne Vulgaris
July 2022 | Volume 21 | Issue 7 | Original Article | 713 | Copyright © July 2022
Background: Although truncal acne is thought to have the same pathophysiology as facial acne, treatment response may differ based on body area involvement. Traditionally, prescribers ...
Read MoreFixed-Combination Halobetasol Propionate/Tazarotene Lotion for Psoriasis in Patients With 3%–5% Affected Body Surface Area
August 2021 | Volume 20 | Issue 8 | Original Article | 829 | Copyright © August 2021
Introduction: Patients with psoriasis and low body surface area (BSA) involvement often experience substantially reduced quality of life and may be candidates for topical therapies. F...
Read MoreSuccessful Treatment of Lichen Amyloidosis Using a Fixed Combination of Halobetasol-Propionate and Tazarotene Lotion
March 2021 | Volume 20 | Issue 3 | Case Reports | 336 | Copyright © March 2021
